New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 25, 2013
15:34 EDTBIDU, BMRN, MXIM, EMN, CERN, SBUX, EXPE, ALTR, RSG, CB, AMZN, VRSN, KLAC, PFG, RRCNotable companies reporting after market close
Notable companies reporting after the market close, with earnings consensus, include Amazon (AMZN), consensus 9c; Starbucks (SBUX), consensus 48c; Baidu (BIDU), consensus $1.03; Chubb (CB), consensus $1.74; Cerner (CERN), consensus 63c; Range Resources (RRC), consensus 28c; Republic Services (RSG), consensus 40c; Eastman Chemical (EMN), consensus $1.57; Principal Financial Group (PFG), consensus 74c; Altera (ALTR), consensus 33c; Maxim Integrated Products (MXIM), consensus 42c; KLA-Tencor (KLAC), consensus 86c; Expedia (EXPE), consensus 23c; BioMarin Pharmaceutical (BMRN), consensus (29c); VeriSign (VRSN), consensus 54c.
News For AMZN;SBUX;BIDU;CB;CERN;RRC;RSG;EMN;PFG;ALTR;MXIM;KLAC;EXPE;BMRN;VRSN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | all recent news | >>
January 14, 2015
06:57 EDTPFGPrincipal Financial upgraded to Outperform from Market Perform at Raymond James
Subscribe for More Information
06:16 EDTRRCRange Resources upgraded to Overweight from Equal Weight at Barclays
Subscribe for More Information
January 13, 2015
16:00 EDTAMZNOptions Update; January 13, 2015
iPath S&P 500 VIX Short-Term Futures up 66c to 34.42. Option volume leaders: AAPL JNJ CELG WFM TSLA TWTR AMZN GILD according to Track Data.
14:11 EDTAMZNAmazon.com climbs after Citi upgrades to buy
Subscribe for More Information
10:30 EDTAMZNAmazon.com tests $300, levels to watch
Subscribe for More Information
10:08 EDTALTRHigh option volume stocks
Subscribe for More Information
10:00 EDTAMZNOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:01 EDTAMZNAmazon Studios signs Woody Allen to create television series
Subscribe for More Information
08:53 EDTBMRNProsensa announces holder approval of certain matters relating to BioMarin
Subscribe for More Information
07:28 EDTAMZNAmazon says created, filled over 6,000 permanent jobs across EU in 2014
Subscribe for More Information
07:26 EDTAMZNAmazon.com survey suggests solid growth trends, says RW Baird
Baird said their recent inventory survey for Amazon.com suggests solid growth trends in selection and marketplace. The firm sees the selection as a key growth driver for Amazon retail. Baird reiterated its Outperform rating and $340 price target on Amazon shares.
06:16 EDTAMZNAmazon.com upgraded to Buy from Neutral at Citigroup
Citigroup upgraded Amazon.com to Buy saying the risk/reward on shares is attractive below $300. Citi believes holiday data points look good for Amazon's Q4 results and that the retailer's gross margins will rise in 2015, reversing 2014's downward trend. The firm raised its price target for Amazon to $354 from $325 and thinks the stock has support around $300. Shares of the retailing giant closed yesterday down $5.52 to $291.41.
06:07 EDTAMZNAmazon sued for $25M by Durst Organization, Forbes reports
Subscribe for More Information
January 12, 2015
16:00 EDTAMZNOptions Update; January 12, 2015
iPath S&P 500 VIX Short-Term Futures up 1.57 to 33.54. Option volume leaders: AAPL TSLA TWTR AMZN AA SIRI RIG FRO C according to Track Data.
14:35 EDTBIDUNuance calls active after blog predicts possible Baidu buyout
Subscribe for More Information
14:12 EDTBIDUNuance ticks higher after blog predicts possible Baidu buyout
Subscribe for More Information
13:47 EDTBMRNBioMarin says BMN 190 appeared to show stabilization of disease in study
Subscribe for More Information
13:34 EDTBMRNBioMarin raises 2014 Vimizim sales outlook to $75M-$77M
Subscribe for More Information
09:04 EDTAMZNAmazon wins first Golden Globe for 'Transparent,' Business Insider reports
Subscribe for More Information
07:57 EDTBMRNBioMarin reiterated as a top mid-cap pick at UBS
UBS reiterated BioMarin as a top mid-cap pick for 2015 following meetings with management. The firm cited the breadth of its pipeline and robust catalysts over the next 12-18 months and the closing of its Prosensa acquisition, which will accelerate revenue growth and profitability over the long-term. UBS reiterated its Buy rating and $112 price target on BioMarin shares.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use